Analyze Diet

Topic:Efficacy

Efficacy in horses refers to the effectiveness of interventions, treatments, or management practices in achieving desired outcomes in equine health and performance. This concept is widely applied in veterinary medicine, nutrition, and training methodologies to assess the impact of various approaches on horse well-being and productivity. Evaluating efficacy involves controlled studies and trials that measure specific parameters such as recovery time, performance metrics, or physiological responses. This topic encompasses a range of research articles and studies that investigate the effectiveness of pharmaceuticals, supplements, therapeutic techniques, and management strategies in horses. The compiled literature provides insights into methodologies for assessing efficacy, results of specific interventions, and implications for equine care and management.
Hippotherapy: a systematic mapping review of peer-reviewed research, 1980 to 2018.
Disability and rehabilitation    September 6, 2019   Volume 43, Issue 10 1463-1487 doi: 10.1080/09638288.2019.1653997
Wood WH, Fields BE.Comprehensively and systematically map peer-reviewed studies of hippotherapy published over 30 years, from 1980 through 2018, from the perspective of a phased scientific approach to developing complex interventions as a guide to future research and practice. A systematic mapping review of research of hippotherapy was conducted. Searches of nine databases produced 3,528 unique records; 78 full-text, English-written studies were reviewed, the earliest of which was published in 1998. Data relevant to study aims were extracted electronically from these studies and analyzed using queries and pivot ...
The efficacy and safety of velagliflozin over 16 weeks as a treatment for insulin dysregulation in ponies.
BMC veterinary research    February 26, 2019   Volume 15, Issue 1 65 doi: 10.1186/s12917-019-1811-2
Meier A, de Laat M, Reiche D, Fitzgerald D, Sillence M.A previous six-week (wk) study demonstrated the potential of the sodium-glucose linked transport inhibitor velagliflozin as a novel treatment for equine insulin dysregulation. The present study examined the safety and efficacy of velagliflozin over 16 wk. of treatment, and over 4 wk. of withdrawal. Twenty-four insulin dysregulated ponies were selected, based on their hyper-responsiveness to a diet challenge meal containing 3.8 g non-structural carbohydrates (NSC)/kg bodyweight (BW). Ponies with serum insulin > 90 μIU/mL either 2 or 4 h after feeding were enrolled, and randomly allocated...
Allogeneic Adipose-Derived Mesenchymal Stem Cells (Horse Allo 20) for the Treatment of Osteoarthritis-Associated Lameness in Horses: Characterization, Safety, and Efficacy of Intra-Articular Treatment.
Stem cells and development    August 10, 2018   Volume 27, Issue 17 1147-1160 doi: 10.1089/scd.2018.0074
Mariñas-Pardo L, García-Castro J, Rodríguez-Hurtado I, Rodríguez-García MI, Núñez-Naveira L, Hermida-Prieto M.Osteoarthritis commonly causes lameness in the horse and has a great impact in performance animals. Due to the limitations of current medical therapies, allogenic mesenchymal stem cells (MSCs) may become an alternative method to control inflammation, reduce tissue damage and pain, and therefore improve lameness. We present the results of a regulatory clinical trial testing adipose-derived MSCs (Horse Allo 20) in veterinary (Agencia Española del Medicamento y Productos Sanitarios, Spanish Medicines Agency, Reference number 325/ECV) involving a total number of 80 participants and with 90 days o...
Efficacy of Tulathromycin for the Treatment of Foals with Mild to Moderate Bronchopneumonia.
Journal of veterinary internal medicine    April 19, 2017   Volume 31, Issue 3 901-906 doi: 10.1111/jvim.14717
Rutenberg D, Venner M, Giguère S.There is conflicting data regarding the efficacy of tulathromycin for the treatment of foals with bronchopneumonia. Tulathromycin is effective for the treatment of bronchopneumonia in foals and noninferior to the combination of azithromycin and rifampin. A total of 240 foals on a farm endemic for infections caused by Rhodococcus equi. In a controlled, randomized, and double-blinded clinical trial, foals with ultrasonographic pulmonary lesions (abscess score 10-15 cm) were allocated to 3 groups: 1-tulathromycin IM q 7 days (n = 80); 2-azithromycin-rifampin, orally q24h (n = 80); or 3-untreated ...
Autologous Conditioned Serum.
Physical medicine and rehabilitation clinics of North America    October 30, 2016   Volume 27, Issue 4 893-908 doi: 10.1016/j.pmr.2016.06.003
Evans CH, Chevalier X, Wehling P.Autologous conditioned serum was developed in the mid 1990s as an expeditious, practical, and relatively inexpensive means of generating the interleukin-1 receptor antagonist, a naturally occurring inhibitor of the cytokine interleukin-1. The latter is thought to be an important mediator of inflammation, pain, and tissue destruction in musculoskeletal conditions. ACS has been widely and successfully used in the local treatment of human and equine osteoarthritis and radicular compression; it has also shown promise in treating tendinopathies, muscle injuries, and tunnel widening after reconstruc...
Autism spectrum disorder and pet therapy.
Advances in mind-body medicine    April 2, 2015   Volume 29, Issue 2 22-25 
Siewertsen CM, French ED, Teramoto M.Autism Spectrum Disorder (ASD) encompasses a wide range of social and mental afflictions that are difficult to treat. Due to a lack of established treatments for ASD, alternative therapies have been the primary form of intervention. One of these alternatives is pet therapy, a field that has experienced growing interest and has recently accumulated studies that investigate its efficacy. This article reviews and summarizes that effectiveness as well as the findings and limitations associated with pet therapy for ASD. The majority of research on ASD and pet therapy has examined children and has p...
Owners’ perception of the efficacy of Newmarket bloodroot ointment in treating equine sarcoids.
The Canadian veterinary journal = La revue veterinaire canadienne    July 2, 2014   Volume 55, Issue 7 683-686 
Wilford S, Woodward E, Dunkel B.A retrospective questionnaire-based survey was used to determine the perceived efficacy of Newmarket bloodroot ointment in treating equine sarcoids. In 49 horses with 74 sarcoids, 64 sarcoids responded either completely (n = 49) or partially (n = 15) while 10 did not respond or worsened. Sarcoids < 2 cm responded better to treatment (P < 0.001) than did larger sarcoids. Un sondage rétrospectif réalisé par questionnaire a été utilisé pour déterminer l’efficacité perçue de l’onguent à la sanguinaire de Newmarket pour traiter les sarcoïdes équines. Chez 49 chevaux atteints ...
Field study on the efficacy of an oral 2% ivermectin formulation in horses. Cutolo AA, Santos AT, Allegretti SM.Twenty horses naturally infected with nematodes were included in a blind, controlled field study on efficacy and safety of an oral 2% ivermectin formulation at a dose of 0.2 mg.kg(-1). Horses were divided into treated and non-treated (control) groups with ten animals each based on preliminary counts of eggs per gram of feces (EPG). Stool samples were collected after treatment for identification of nematode species. Clinical evaluations and EPG counts were performed on days 0, +5, +14 and +19. Nineteen nematode species were identified: Coronocyclus ulambajari, Craterostomum acuticaudatum, Cyath...
Evidence-based medicine and stem cell therapy: how do we know such technologies are safe and efficacious?
The Veterinary clinics of North America. Equine practice    June 12, 2011   Volume 27, Issue 2 373-382 doi: 10.1016/j.cveq.2011.04.002
Clegg PD, Pinchbeck GL.Evidence-based medicine (EBM) refers to the conscientious, explicit, and judicious use of current best evidence from research for the care of an individual patient. Central to the adoption of EBM is both producing and identifying the best possible evidence for a particular intervention or therapy. This article identifies and reviews the approaches to producing and identifying the best possible evidence that is necessary for the full acceptance of stem cell therapies in the horse and reviews the approaches that will allow future clinical studies in stem cell therapies to provide the best eviden...
Effect of topical vapocoolant spray on response to arthrocentesis and intravenous catheterization in unsedated horses.
American journal of veterinary research    June 2, 2011   Volume 72, Issue 6 746-750 doi: 10.2460/ajvr.72.6.746
Fjordbakk CT, Haga HA.To assess the efficacy of a commercially available topical vapocoolant spray in reducing responses to arthrocentesis of the middle carpal (MC) and metacarpophalangeal (MCP) joints and jugular vein catheterization in unsedated horses. Methods: 8 healthy research horses. Methods: Arthrocentesis of both MC and MCP joints and bilateral jugular vein catheterization were performed in each horse. Immediately prior to skin penetration, 1 randomly selected MC joint, MCP joint, and jugular vein were sprayed with a vapocoolant liquid (intervention product), and the contralateral MC joint, MCP joint, and ...
Efficacy of Cymelarsan and Diminasan against Trypanosoma equiperdum infections in mice and horses.
Veterinary parasitology    April 2, 2010   Volume 171, Issue 3-4 200-206 doi: 10.1016/j.vetpar.2010.03.041
Hagos A, Goddeeris BM, Yilkal K, Alemu T, Fikru R, Yacob HT, Feseha G, Claes F.Trypanocidal sensitivity studies were conducted to assess the efficacy of Diminazene diaceturate (Diminasan) and Bis (aminoethylthio) 4-melaminophenylarsine dihydrochloride (Cymelarsan) against Trypanosoma equiperdum (isolated from two mares with chronic cases of dourine) 713/943 and 834/940 Dodola strains in experimentally infected mice and horses. Diminasan at doses from 3.5 mg/kg to 28 mg/kg and Cymelarsan at doses of 0.25 mg/kg and 0.5 mg/kg body weight failed to cure any of the mice, indicating a clear dose dependent relationship in the mean time of relapse observed in mice. Indeed, mice ...
Comparative plasma disposition, bioavailability and efficacy of ivermectin following oral and pour-on administrations in horses.
Veterinary parasitology    February 4, 2010   Volume 170, Issue 1-2 120-126 doi: 10.1016/j.vetpar.2010.01.041
Gokbulut C, Cirak VY, Senlik B, Aksit D, Durmaz M, McKellar QA.Pour-on formulations of endectocides decrease the risk of injury for both user and animal, and are particularly convenient for animal owners who can apply the product. This study was designed to investigate the plasma disposition and efficacy of ivermectin (IVM) following pour-on, per os and intravenous administrations. Eighteen female horses weighing 510-610 kg were used in this study. The animals were allocated into three groups (per os, pour-on and intravenous groups). The equine paste, bovine pour-on and bovine injectable formulations of IVM were administered orally, topically and intraven...
Pharmacological assessment of netobimin as a potential anthelmintic for use in horses: plasma disposition, faecal excretion and efficacy.
Research in veterinary science    November 20, 2008   Volume 86, Issue 3 514-520 doi: 10.1016/j.rvsc.2008.10.001
Gokbulut C, Cirak VY, Senlik B, Yildirim F, McKellar QA.This study aimed to determine the plasma disposition and faecal excretion of netobimin (NTB) and its respective metabolites as well as the efficacy against strongyles in horses following oral administration. Netobimin (10mg/kg) was administered orally to 8 horses. Blood and faecal samples were collected from 1 to 120h post-treatment and analysed by high performance liquid chromatography (HPLC). Using a chiral phase-based HPLC, plasma disposition of ABZSO enantiomers produced was also determined. Faecal strongyle egg counts (EPG) were performed by a modified McMaster's technique before and afte...
Evidence-based drug use in equine medicine and surgery.
The Veterinary clinics of North America. Equine practice    July 10, 2007   Volume 23, Issue 2 201-213 doi: 10.1016/j.cveq.2007.04.005
Bertone JJ.The nature of the equine industry and equine veterinary medicine often requires veterinarians to prescribe drugs with little evidence for a drug's formulation safety or efficacy, or even assurance of the chemistry of the drug used. This means that equine veterinarians must remain skeptics and understand the limitations in their ability to attribute safety and efficacy to a particular drug or treatment. An evidence-based approach to pharmacology demands rigorous testing and an unbiased analysis of results.
Efficacy of oral and intravenous dexamethasone in horses with recurrent airway obstruction.
Equine veterinary journal    July 16, 2004   Volume 36, Issue 5 426-430 doi: 10.2746/0425164044868413
Cornelisse CJ, Robinson NE, Berney CE, Kobe CA, Boruta DT, Derksen FJ.Although the efficacy of dexamethasone for the treatment of recurrent airway obstruction (RAO) has been documented, the speed of onset of effect and duration of action are unknown, as is the efficacy of orally administered dexamethasone with or without fasting. Objective: To document the time of onset of effect and duration of action of a dexamethasone solution i.v. or orally with and without fasting. Methods: Protocol 1 used 8 RAO-affected horses with airway obstruction in a crossover design experiment that compared the effect of i.v. saline and dexamethasone (0.1 mg/kg bwt) on pulmonary func...
Field evaluation of moxidectin/praziquantel oral gel in horses.
Veterinary therapeutics : research in applied veterinary medicine    May 12, 2004   Volume 4, Issue 3 249-256 
Grubbs ST, Amodie D, Rulli D, Wulster-Radcliffe M, Reinemeyer C, Yazwinski T, Tucker C, Hutchens D, Smith L, Patterson D.The safety and efficacy of 2% moxidectin/12.5% praziquantel oral gel administered at a rate of 0.4 mg moxidectin and 2.5 mg praziquantel/kg was studied in client-owned horses under field use conditions. Four hundred horses (300 treated with moxidectin/praziquantel oral gel and 100 treated with vehicle) were enrolled, feces were collected, and eggs were counted. Investigators as well as horse owners were masked to treatment assignment. No adverse reactions to treatment were observed in any horses. Moxidectin/praziquantel gel reduced Anoplocephala spp by more than 99% and provided a significant ...
[Efficacy of probiotic feed additives: guidelines for the evaluation of the efficiency of microorganisms in dogs, cats, and horses].
DTW. Deutsche tierarztliche Wochenschrift    February 13, 2002   Volume 109, Issue 1 22-25 
Lahrssen M, Zentek J.Probiotic microorganisms are frequently in use as feed additives for farm and pet animals. For admission for the common market products have to be tested according to the feed additive directive 70/524/EC. The dossier for admission has to comprise data of efficiency as laid down in the directive 87/153/EC. During the last years it became obvious after the evaluation of several dossiers, that no definitive criteria for the assessment of efficacy were available for dogs, cats and horses (84/153/EC). Aspects like the promotion of animal production are not relevant in this context. Therefore, the ...
Efficacy of moxidectin 2 per cent gel against naturally acquired strongyle infections in horses, with particular reference to larval cyathostomes.
The Veterinary record    March 29, 2001   Volume 148, Issue 5 138-141 doi: 10.1136/vr.148.5.138
Bairden K, Brown SR, McGoldrick J, Parker LD, Talty PJ.The efficacy of moxidectin 2 per cent equine gel against naturally acquired strongyle infections was assessed in 18 ponies which had grazed on contaminated pasture before being housed for eight weeks. Twenty-four hours before the treatment, two randomly selected ponies were euthanased and their worm burdens were determined. Eight of the remaining 16 ponies were treated with moxidectin 2 per cent gel while the other eight were given a placebo gel. Eight weeks later the 16 animals were necropsied and their worm burdens established. A 100 per cent efficacy was recorded against adult and lumenal L...
Pilot study to investigate the efficacy of a 1 per cent selenium sulphide shampoo in the treatment of equine chorioptic mange.
The Veterinary record    July 15, 1999   Volume 144, Issue 24 674-675 doi: 10.1136/vr.144.24.674
Curtis CF.No abstract available
Efficacy of moxidectin 2% oral gel against second- and third-instar Gasterophilus intestinalis De Geer.
The Journal of parasitology    June 30, 1998   Volume 84, Issue 3 656-657 
Scholl PJ, Chapman MR, French DD, Klei TR.In a trial designed to evaluate the efficacy of the recommended dosage of moxidectin 2% oral gel against the gastric stages of Gasterophilus spp., 14 ponies were selected from a herd on the basis of the inclusion criterion of the presence of Gasterophilus spp. eggs attached to their hair coats. After random allocation, the ponies were treated with 1 of 2 treatments, moxidectin 2% equine gel in a single dose at the commercial dosage of 400 microg moxidectin/kg body weight or placebo gel. The animals were necropsied 14 days posttreatment. Efficacies against second- and third-instar Gasterophilus...
Efficacy of moxidectin 2% equine gel against natural nematode infections in ponies.
Veterinary parasitology    March 11, 1998   Volume 74, Issue 1 85-89 doi: 10.1016/s0304-4017(97)00144-1
Dorchies P, de Lahitte JD, Flochlay A, Blond-Riou F.The efficacy of moxidectin 2% oral gel (Equest, Fort-Dodge) against European worm strains was studied through post-mortem worm counts and feacal egg counts (FECs) in 12 young ponies naturally infected. The animals were allocated in two groups of six ponies each: the first one was treated at 0.4 mg/kg b.w. and the second one received a placebo and served as control. All the ponies were necropsied 14 days post-treatment. The efficacy of moxidectin in reducing strongyle FECs ranged from 99.8% to 100% from 3 to 14 days after treatment. Moxidectin efficacy was 100% against Trichostrongylus axei and...
[Efficacy of the oral antiparasitic mebendazole plus trichlorfon (telmin plus trichlorfon) against Gasterophilus in the horse].
Schweizer Archiv fur Tierheilkunde    January 1, 1993   Volume 135, Issue 11-12 356-359 
Brocard P, Pfister K.The combined drug Mebendazole plus Trichlorfon (Telmin plus Trichlorfon, Janssen Pharmaceutica, Beerse/Belgium) has been tested in a field trial against naturally acquired Gasterophilus spp. infestations in horses. 44 foals (1 to 1.5 years old, 350-450 kg body-weight) originating from different endemic areas of Switzerland, have been randomly allocated to two groups as follows: 28 foals were treated with Mebendazole plus Trichlorfon, 16 animals served as untreated controls. The drug (paste) was administered and dosed according to the user's instruction. Macroscopic examinations of the digestiv...
Safety and efficacy of a thymidine kinase negative equine herpesvirus-1 vaccine in young horses. Cornick J, Martens J, Martens R, Crandell R, McConnell S, Kit S.A drug induced equine herpesvirus-1 (EHV-1) mutant lacking thymidine kinase inducing activity was developed and evaluated as a vaccine. The safety and effectiveness of the vaccine to protect against experimentally induced EHV-1 respiratory disease were evaluated in weanling horses free of EHV-1 neutralizing antibody. The vaccine was safe when administered either intramuscularly or intravenously, and EHV-1 was not shed intranasally during the 12 days following administration. Intranasal challenge with virulent EHV-1 was used to evaluate vaccine efficacy. Following challenge, there was a signifi...
Efficacy of ivermectin in paste and injectable formulations against microfilariae of Onchocerca cervicalis and resolution of associated dermatitis in horses.
American journal of veterinary research    September 1, 1988   Volume 49, Issue 9 1550-1554 
French DD, Klei TM, Foil CS, Miller RI, Foil LD, Chapman MR, McClure JJ.The efficacy of a single dose of ivermectin (0.2 mg/kg), in injectable or paste formulations, against microfilariae of Onchocerca cervicalis and associated skin lesions was evaluated in 20 naturally infected horses during midsummer months in Louisiana. All horses had clinical signs of dermatitis of the ventral midline and/or limbs, shoulders, thorax, and withers. Efficacy was monitored at 21, 42, and 63 days after treatment. Procedures done at these intervals included microfilarial counts of 6-mm skin biopsy specimens of affected ventral midline, grading of gross lesions, and photography and h...
Efficacy of an oxibendazole-trichlorfon paste formulation against third stage larvae of Gasterophilus intestinalis and its safety in horses.
The Veterinary record    September 20, 1986   Volume 119, Issue 12 294-296 doi: 10.1136/vr.119.12.294
Bauer C, Bürger HJ.A paste formulation containing 14.3 per cent of oxibendazole and 44 per cent of trichlorfon was administered to 33 ponies and horses. The dose rate used was equivalent to 10 mg and 30 mg/kg bodyweight, of oxibendazole and trichlorfon respectively. After treatment 25 animals passed between one and 82 third stage larvae of Gasterophilus intestinalis in their faeces. Dosing with 0.2 mg ivermectin/kg bodyweight three weeks later resulted in six animals expelling between one and four bots. The efficacy of the oxibendazole-trichlorfon paste was on average 96.2 per cent. This drug combination given t...
Ivermectin: a review of efficacy and safety.
Journal of veterinary pharmacology and therapeutics    March 1, 1984   Volume 7, Issue 1 1-16 doi: 10.1111/j.1365-2885.1984.tb00872.x
Campbell WC, Benz GW.No abstract available
Efficacy of ivermectin in injectable and oral paste formulations against eight-week-old Strongylus vulgaris larvae in ponies.
American journal of veterinary research    January 1, 1984   Volume 45, Issue 1 183-185 
Klei TR, Torbert BJ, Chapman MR, Turk MA.A controlled test method was used to evaluate the efficacy of injectable micelle and oral paste formulations of ivermectin (22,23-dihydroavermectin B1) against 8-week-old Strongylus vulgaris larvae in experimentally infected pony foals. The dosage level of the drug in both formulations tested was 0.2 mg/kg. Ponies were euthanatized and necropsied 5 weeks after treatment. Based on the recovery of live vs dead S vulgaris from mesenteric arteries, both formulations were greater than 99% effective. Increased weight gains and marked reductions in the severity of arterial lesions were observed in tr...
Effectiveness of fenbendazole against later 4th-stage Strongylus vulgaris in ponies.
American journal of veterinary research    December 1, 1983   Volume 44, Issue 12 2285-2289 
Slocombe JO, McCraw BM, Pennock PW, Baird JD.Twelve pony foals (reared worm-free) were inoculated with Strongylus vulgaris. Approximately 8 weeks later, 4 of the foals were given fenbendazole (10% suspension) at a dosage rate of 10 mg/kg of body weight daily for 5 days and 4 foals were given the suspension at a dosage rate of 50 mg/kg daily for 3 days; the remaining foals were given a placebo. All treatments were administered by stomach tube. Fenbendazole was 99.6 and 97.9% effective in the 2 treatment groups, respectively, in eliminating later 4th-stage S vulgaris larvae located near the origin of major intestinal arteries. On microscop...
Anthelmintic activity of paste and drench formulations of oxfendazole in horses.
The Veterinary record    October 31, 1981   Volume 109, Issue 18 404-407 doi: 10.1136/vr.109.18.404
Kingsbury PA, Reid JF.Oxfendazole was administered in paste or drench formulations to groups of five horses carrying naturally acquired worm burdens. At a dose rate of 10 mg/kg the efficacy of either formulation appeared similar. One hundred per cent of the adult populations of the following genera was removed: Parascaris, Oxyuris, Strongylus (S edentatus, S vulgaris), Triodontophorus and Trichostrongylus axei. Efficacy against adult small strongyles, adult Habronema microstoma and immature Oxyuris equi was in the region of 96 to 99 per cent. The level of efficacy against immature small strongyles was at least 74 t...
Efficacy of an oral larvicide in controlling horse bots.
Veterinary medicine, small animal clinician : VM, SAC    August 1, 1981   Volume 76, Issue 8 1207-1209 
Sharp AJ, Pennington RG, Scroggs MG, Miller WV.No abstract available